Pfizer Caught in Yet More Science Fraud: Company Altered Study Findings Over Neurontin Drug

A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers said on Wednesday, offering a look at how drugmakers influence scientific research.'

Read more...